Nice | Empagliflozin in Type 2 Diabetes

This is a new guideline from Nice. Empagliflozin is a selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor, which blocks glucose reabsorption in the kidneys and so causes increased urinary excr...

Read more

Nice | Canagliflozin in Type 2 diabetes

This new guideline from NICE outlines when canagliflozin can be used. This is an SGLT2 inhibitor (selective sodium-glucose cotransporter-2). It blocks reabsorption of glucose in the kidneys, so increa...

Read more

BASHH | Use of androgens

Guidelines on the management of sexual problems in men and women – the use of androgens These are short and worth a read – there are useful summaries on the back pages. They encourage screening men an...

Read more